Nexentis Technologies (NXTS) Cash & Equivalents (2018 - 2026)
Nexentis Technologies (NXTS) posted Cash & Equivalents of $7.62 million for Q2 2026, up 142.9% from $3.14 million a year earlier.
Powered by 
Analysis
Nexentis Technologies (NXTS) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Nexentis Technologies' Cash & Equivalents came in at $3.83 million, up 99.3% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 73.6% (FY2020 to FY2025).
- In prior years, Nexentis Technologies' Cash & Equivalents was $1.92 million in FY2024 (-56.8%), $4.45 million in FY2023 (-22.0%), $5.7 million in FY2022 (-15.6%) and $6.75 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q3 2021.
- On a year-over-year basis, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 42.2%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2026, with growth of 142.9%; the weakest was Q3 2023, with a decline of 71.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Nexentis Technologies | 1.17 Mn | -21.60 Mn | - | 7.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.62 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | 6.04 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 4.47 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 4.45 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 5.70 Mn |
| Sep 30, 2022 | 6.69 Mn |
| Jun 30, 2022 | 4.38 Mn |
| Mar 31, 2022 | 5.64 Mn |
| Dec 31, 2021 | 6.75 Mn |
| Sep 30, 2021 | 7.77 Mn |
| Jun 30, 2021 | 9.31 Mn |
API Access
Nexentis Technologies Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();